The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Sep. 25, 2018

Filed:

Aug. 14, 2017
Applicants:

Viktor Veniaminovich Tets, St. Petersburg, RU;

Georgy Viktorovich Tets, St. Petersburg, RU;

Inventors:

Viktor Veniaminovich Tets, St. Petersburg, RU;

Georgy Viktorovich Tets, St. Petersburg, RU;

Viktor Iosifovich Krutikov, St. Petersburg, RU;

Assignee:

Other;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/63 (2006.01); A61K 9/06 (2006.01); A61K 9/00 (2006.01); A61K 9/02 (2006.01); A61K 9/10 (2006.01);
U.S. Cl.
CPC ...
A61K 31/63 (2013.01); A61K 9/0014 (2013.01); A61K 9/0034 (2013.01); A61K 9/02 (2013.01); A61K 9/06 (2013.01); A61K 9/10 (2013.01);
Abstract

The invention relates to medicine and specifically to methods for treating recurring forms of diseases related to the family of herpes viruses. A method for treating recurring diseases of the skin and mucous membranes caused by HSV-1 and HSV-2 involves applying a preparation to an affected area, said preparation including a base containing 0.5% or 1% of an active substance, namely a (2,6-dichlorophenyl)amide salt of carbopentoxysulfanilic acid of general formula (I): where X is Na, K, NH; the preparation is applied twice daily for 3-5 days and, should prodromes appear, a second course of treatment is carried out, in which the preparation is applied 1-2 times daily for 2-3 days; the base containing the active substance can be in the form of a cream, an ointment, a gel, a suspension, suppositories, a patch or a film. Carrying out the second course of treatment provides a sharp increase in therapeutic efficacy, even to the extent of preventing relapse over a prolonged period of observation as a result of the effect of the preparation, upon reuse, on the viruses persisting in nerve cells.


Find Patent Forward Citations

Tets, Viktor. (2018). Method for treating recurring skin and mucous membrane diseases caused by hsv-1 and hsv-2 (U.S. Patent No. 10080761). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/10080761

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…